Leafly Holdings Retained Earnings (Accumulated Deficit) 2020-2024 | LFLY

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Leafly Holdings retained earnings (accumulated deficit) from 2020 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.

Leafly Holdings Retained Earnings (Accumulated Deficit) 2020-2024 | LFLY

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$203.4B
Stryker (SYK)	$148.7B
Boston Scientific (BSX)	$134.9B
EssilorLuxottica (ESLOY)	$111.5B
Medtronic (MDT)	$108.7B
Haleon (HLN)	$43.2B
Lonza Group Ag (LZAGY)	$42.4B
GE HealthCare Technologies (GEHC)	$37.5B
ResMed (RMD)	$35.8B
Terumo (TRUMY)	$29.4B
Koninklijke Philips (PHG)	$24.8B
Zimmer Biomet Holdings (ZBH)	$21.6B
Insulet (PODD)	$18.4B
Baxter (BAX)	$16.8B
Smith & Nephew SNATS (SNN)	$10.9B
BellRing Brands (BRBR)	$9.9B
Bio-Rad Laboratories (BIO)	$9.1B
Demant (WILYY)	$8.3B
Lantheus Holdings (LNTH)	$6.1B
TG Therapeutics (TGTX)	$5.4B
Haemonetics (HAE)	$4.3B
Prestige Consumer Healthcare (PBH)	$4.2B
ICU Medical (ICUI)	$4.1B
Perrigo (PRGO)	$3.7B
Envista Holdings (NVST)	$3.7B
Agios Pharmaceuticals (AGIO)	$3.2B
Neogen (NEOG)	$3.2B
Shandong Weigao Medical Polymer (SHWGF)	$3B
GN Store Nord (GNNDY)	$2.8B
QuidelOrtho (QDEL)	$2.5B